NCT05433987View on ClinicalTrials.gov

Immune Activation Markers in HIV-infected Patients Switching to Long Acting Dual Therapy

CompletedOBSERVATIONAL

Enrollment

20

Participants

Timeline

Start Date

July 28, 2022

Primary Completion Date

November 17, 2023

Study Completion Date

November 17, 2023

Conditions

HIV-1-infection

Trial Locations (1)

06414

Nathalie DOUX, Cannes

All Listed Sponsors

lead

Centre Hospitalier de Cannes Simone Veil

OTHER